News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Saad Mark E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2023 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,681 options to buy
@ $74.12, valued at
$421.1k
|
|
| 03/06/2023 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,224 options to buy
@ $65.32, valued at
$145.3k
|
|
| 06/07/2022 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 16,976 options to buy
@ $25.53, valued at
$433.4k
|
|
| 03/08/2022 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,337 options to buy
@ $29.91, valued at
$69.9k
|
|
| 11/19/2021 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $34.5324, valued at
$103.6k
Bought 100 shares
@ $34.395, valued at
$3.4k
Bought 100 shares
@ $34.45, valued at
$3.4k
Bought 100 shares
@ $34.4, valued at
$3.4k
|
|
| 06/08/2021 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 7,325 options to buy
@ $61.32, valued at
$449.2k
|
|
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Granted 8,227 shares
@ $0 |
|
| 10/14/2020 |
4
| Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 06/05/2020 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $77.38, valued at
$1M
|
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2020 |
4
| Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Granted 49,576 options to buy
@ $1.18, valued at
$58.5k
|
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Granted 29,850 shares
@ $0 |
|
| 05/24/2019 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 3,500 shares
@ $22.33, valued at
$78.2k
|
|
| 03/21/2019 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 29,387 options to buy
@ $12.95, valued at
$380.6k
|
|
| 10/05/2018 |
4
| Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Granted 8,235 shares
@ $0 |
|
| 06/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2018 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 32,602 options to buy
@ $2.85, valued at
$92.9k
|
|
| 03/17/2017 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc. |
| 06/01/2016 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 6,231 options to buy
@ $8.02, valued at
$50k
|
|
| 11/24/2015 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Converted 3,502 shares
@ $5.94, valued at
$20.8k
Granted 3,502 convertible notes
@ $5.94, valued at
$20.8k
|
|
| 11/23/2015 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 9,127 options to buy
@ $9, valued at
$82.1k
|
|
| 04/15/2014 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.|
Txns:
| Granted 170,000 options to buy
@ $2.38, valued at
$404.6k
|
|
| 02/04/2013 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.|
Txns:
| Disposed/sold 14,070 shares
@ $0
Granted 150,000 options to buy
@ $2.74, valued at
$411k
Granted 75,000 options to buy
@ $5, valued at
$375k
|
|
| 03/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2012 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.|
Txns:
| Disposed/sold 33,500 shares
@ $0
Granted 33,500 shares
@ $0
Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $3.44, valued at
$137.6k
|
|
| 08/12/2011 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.|
Txns:
| Bought 2,600 shares
@ $3.1, valued at
$8.1k
Bought 400 shares
@ $3.12, valued at
$1.2k
Bought 800 shares
@ $3.13, valued at
$2.5k
Bought 2,700 shares
@ $3.14, valued at
$8.5k
|
|
| 03/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2011 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $5.57, valued at
$278.5k
|
|
| 05/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2010 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $6.71, valued at
$671k
|
|
| 02/02/2009 |
4
| Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC. |
|
|